Healthequity (HQY) Common Equity (2014 - 2026)

Healthequity's Common Equity history runs 13 years deep, the most recent figure standing at $2.0 billion for Q2 2026.

• On a quarterly basis, Common Equity fell 3.6% year-over-year to $2.0 billion in Q2 2026; TTM through Apr 2026 was $2.0 billion, a 3.6% decrease from a year earlier, with the FY2026 full-year figure at $2.1 billion, changed 0.36% from the prior year.
• Common Equity fell to $2.0 billion in Q2 2026 per HQY's latest filing, from $2.1 billion in the prior quarter.
• Across five years, Common Equity topped out at $2.2 billion in Q3 2024 and bottomed at $1.9 billion in Q1 2022.
• The 5-year median for Common Equity is $2.0 billion (2024), against an average of $2.0 billion.
• Across the five-year window, Common Equity soared 34.37% in 2022 and dropped 3.6% in 2026, its largest moves.
• Year by year, Common Equity stood at $1.9 billion in 2022, then climbed by 5.57% to $2.0 billion in 2023, then rose by 6.88% to $2.1 billion in 2024, then grew by 0.44% to $2.1 billion in 2025, then decreased by 4.06% to $2.0 billion in 2026.
• Per Business Quant, the three latest HQY Common Equity figures stand at $2.0 billion (Q2 2026), $2.1 billion (Q1 2026), and $2.1 billion (Q4 2025).